Centro de Investigación de Medicina Aplicada (CIMA)
Centro / Instituto vinculado a la Universidad de Navarra
Hospital Universitario Nuestra Señora de Candelaria
Santa Cruz de Tenerife, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Nuestra Señora de Candelaria (15)
2024
2021
2019
-
High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients
BMC neurology, Vol. 19, Núm. 1, pp. 167
-
Persistently high circulating tissue inhibitor of matrix metalloproteinase-1 levels in non-survivor brain trauma injury patients
Journal of Critical Care, Vol. 51, pp. 117-121
-
X chromosome inactivation does not necessarily determine the severity of the phenotype in Rett syndrome patients
Scientific Reports, Vol. 9, Núm. 1
2018
-
Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer
Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483
2017
-
The utility of Next Generation Sequencing for molecular diagnostics in Rett syndrome
Scientific Reports, Vol. 7, Núm. 1
2015
-
Common variants of NFE2L2 gene predisposes to acute respiratory distress syndrome in patients with severe sepsis
Critical Care, Vol. 19, Núm. 1
-
Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction
BMC Neurology, Vol. 15, Núm. 1
2014
2013
2011
-
Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis
Critical Care, Vol. 15, Núm. 2
2009
-
Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease
Neurobiology of Disease, Vol. 36, Núm. 3, pp. 494-508
-
Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis
Critical Care, Vol. 13, Núm. 5